Passifs Courants Changement Date
AbbVie USD 43.1B 1.46B 2026-09
Align Technology USD 1.91B 4.9M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Charles River Laboratories USD 1.09B 45.49M 2026-09
Coherus Biosciences USD 75.51M 56.82M 2026-06
Dentsply International USD 1.22B 32M 2026-09
Eli Lilly USD 47B 745M 2026-09
Henry Schein USD 3.6B 110M 2026-09
Idexx Laboratories USD 1.26B 23.44M 2026-09
Illumina USD 1.16B 422M 2026-09
IQVIA Holdings USD 7.78B 1.04B 2026-09
J&J USD 55.46B 562M 2026-09
Laboratory Of America USD 2.82B 695M 2026-09
Merck USD 28.8B 1.07B 2026-09
Neogen USD 149.5M 8.7M 2026-06
Pacira USD 126.1M 4.08M 2026-09
Perrigo USD 1.02B 34.4M 2026-09
Pfizer USD 31.73B 920M 2026-09
Phibro Animal Health USD 295.79M 20.68M 2026-09
Quest Diagnostics USD 1.83B 46M 2026-09
Sanofi EUR 29.77B 2.16B 2026-09
Sanofi EUR 31.93B 1.92B 2026-06
Zoetis USD 2.68B 621M 2026-09